AUPH · Aurinia Pharmaceuticals Inc Ordinary Shares
View on chartInsiders & Stakes
| Kevin Tang 10% Owner | ▲ Buy | Open Market | 13,044,106 Shares held | 6/2/2026 | View profile |
| Peter Greenleaf Director | ▼ Sell | Tax Withholding | 1,840,379 Shares held | 3/2/2026 | View profile |
| Matthew Maxwell Donley Ex VP, Intern'l Operations | ▼ Sell | Tax Withholding | 680,299 Shares held | 3/2/2026 | View profile |
| Stephen P. Robertson Chief Legal Officer | ▼ Sell | Open Market | 588,848 Shares held | 9/10/2026 | View profile |
| Joseph M. Miller Chief Financial Officer | ▼ Sell | Tax Withholding | 576,421 Shares held | 3/2/2026 | View profile |
| Habig Scott Michael Chief Commercial Officer | ▼ Sell | Open Market | 456,338 Shares held | 8/6/2024 | View profile |
| Knappertz Volker EVP, Research and Development | ▼ Sell | Open Market | 319,128 Shares held | 2/27/2024 | View profile |
| Martin Michael Robert Chief Business Officer | ▲ Buy | Grant | 259,162 Shares held | 3/2/2023 | View profile |
| Greg Keenan Chief Medical Officer | ▼ Sell | Tax Withholding | 154,449 Shares held | 3/6/2026 | View profile |
| Michael S. Hearne Chief Financial Officer | ▲ Buy | Grant | 116,144 Shares held | 5/18/2026 | View profile |
| Ryan Cole Chief Operating Officer | ▲ Buy | Grant | 116,144 Shares held | 5/18/2026 | View profile |
| Solomons Neil Chief Medical Officer | ▼ Sell | Open Market | 90,953 Shares held | 3/2/2022 | View profile |
| MILNE GEORGE M JR Director | ▲ Buy | Option Exercise | 78,733 Shares held | 5/18/2023 | View profile |
| Huizinga Robert Bindert EVP of Research | ▼ Sell | Open Market | 69,379 Shares held | 3/2/2022 | View profile |
| Jayne David R.W. Director | ▲ Buy | Grant | 56,499 Shares held | 11/21/2024 | View profile |
| Billen Daniel Director | ▼ Sell | Open Market | 28,141 Shares held | 5/21/2024 | View profile |
| Leversage Jill Director | ▲ Buy | Grant | 25,053 Shares held | 11/21/2024 | View profile |
| Smith Karen L. Chief Medical Officer | ▲ Buy | Grant | 24,807 Shares held | 11/21/2024 | View profile |
| Jeffrey Allen Bailey Director | ▼ Sell | Tax Withholding | 22,775 Shares held | 11/21/2025 | View profile |
| MacKay-Dunn R. Hector Director | ▼ Sell | Open Market | 18,595 Shares held | 5/21/2024 | View profile |
| Balakrishnan Brinda Director | ▼ Sell | Open Market | 17,523 Shares held | 5/21/2024 | View profile |
| Craig A. Johnson Director | ▼ Sell | Tax Withholding | 14,592 Shares held | 11/21/2025 | View profile |
| Colao Massimilano Chief Commercial Officer | ▼ Sell | Open Market | 13,495 Shares held | 3/2/2022 | View profile |
| Hagan Joseph P Director | ▼ Sell | Open Market | 11,961 Shares held | 5/19/2023 | View profile |
Transaction History
| Stephen P. Robertson | ▼ Sell | Open Market | 11,939 | $190K | 9/10/2026 |
| Stephen P. Robertson | ▼ Sell | Open Market | 20,975 | $356K | 8/21/2026 |
| Kevin Tang | ▲ Buy | Open Market | 206,005 | $3.1M | 6/2/2026 |
| Kevin Tang | ▲ Buy | Open Market | 343,521 | $5.2M | 6/1/2026 |
| Kevin Tang | ▲ Buy | Open Market | 99 | $2K | 6/1/2026 |
| Kevin Tang | ▲ Buy | Open Market | 2,299 | $35K | 5/29/2026 |
| Kevin Tang | ▲ Buy | Open Market | 262,682 | $4.0M | 5/29/2026 |
| Ryan Cole | ▲ Buy | Grant | 116,144 | $0 | 5/18/2026 |
| Stephen P. Robertson | ▲ Buy | Grant | 115,541 | $0 | 5/18/2026 |
| Michael S. Hearne | ▲ Buy | Grant | 116,144 | $0 | 5/18/2026 |
| Greg Keenan | ▼ Sell | Tax Withholding | 8,069 | $116K | 3/6/2026 |
| Kevin Tang | ▲ Buy | Open Market | 184,208 | $2.6M | 3/3/2026 |
| Kevin Tang | ▲ Buy | Open Market | 83,561 | $1.2M | 3/2/2026 |
| Kevin Tang | ▲ Buy | Open Market | 115,792 | $1.6M | 3/2/2026 |
| Joseph M. Miller | ▼ Sell | Tax Withholding | 37,511 | $533K | 3/2/2026 |
| Matthew Maxwell Donley | ▼ Sell | Tax Withholding | 40,761 | $579K | 3/2/2026 |
| Peter Greenleaf | ▼ Sell | Tax Withholding | 100,890 | $1.4M | 3/2/2026 |
| Stephen P. Robertson | ▼ Sell | Tax Withholding | 36,525 | $519K | 3/2/2026 |
| Kevin Tang | ▲ Buy | Open Market | 300,000 | $4.2M | 2/27/2026 |
| Kevin Tang | ▲ Buy | Open Market | 214,839 | $3.0M | 2/27/2026 |
| Kevin Tang | ▲ Buy | Open Market | 1,600 | $23K | 2/27/2026 |
| Joseph M. Miller | ▲ Buy | Grant | 57,229 | $0 | 2/27/2026 |
| Matthew Maxwell Donley | ▲ Buy | Grant | 58,160 | $0 | 2/27/2026 |
| Peter Greenleaf | ▲ Buy | Grant | 196,403 | $0 | 2/27/2026 |
| Greg Keenan | ▲ Buy | Grant | 40,586 | $0 | 2/27/2026 |
| Stephen P. Robertson | ▲ Buy | Grant | 59,090 | $0 | 2/27/2026 |
| Matthew Maxwell Donley | ▼ Sell | Tax Withholding | 32,901 | $474K | 2/20/2026 |
| Peter Greenleaf | ▼ Sell | Tax Withholding | 100,171 | $1.4M | 2/20/2026 |
| Joseph M. Miller | ▼ Sell | Tax Withholding | 32,424 | $467K | 2/20/2026 |
| Stephen P. Robertson | ▼ Sell | Tax Withholding | 34,638 | $499K | 2/20/2026 |
| Greg Keenan | ▼ Sell | Tax Withholding | 11,552 | $168K | 2/2/2026 |
| Matthew Maxwell Donley | ▲ Buy | Grant | 54,166 | $0 | 1/2/2026 |
| Stephen P. Robertson | ▲ Buy | Grant | 48,558 | $0 | 1/2/2026 |
| Stephen P. Robertson | ▼ Sell | Tax Withholding | 40,385 | $644K | 1/2/2026 |
| Joseph M. Miller | ▲ Buy | Grant | 49,038 | $0 | 1/2/2026 |
| Joseph M. Miller | ▼ Sell | Tax Withholding | 40,161 | $641K | 1/2/2026 |
| Peter Greenleaf | ▲ Buy | Grant | 165,384 | $0 | 1/2/2026 |
| Peter Greenleaf | ▼ Sell | Tax Withholding | 113,169 | $1.8M | 1/2/2026 |
| Matthew Maxwell Donley | ▼ Sell | Tax Withholding | 42,787 | $682K | 1/2/2026 |
| Jeffrey Allen Bailey | ▼ Sell | Tax Withholding | 2,716 | $43K | 11/21/2025 |
| Craig A. Johnson | ▼ Sell | Tax Withholding | 6,039 | $95K | 11/21/2025 |
| Kevin Tang | ▲ Buy | Open Market | 200,000 | $2.3M | 8/5/2025 |
| Kevin Tang | ▲ Buy | Open Market | 100,000 | $1.1M | 8/4/2025 |
| Kevin Tang | ▲ Buy | Open Market | 1,000,000 | $10.1M | 8/1/2025 |
| Greg Keenan | ▼ Sell | Open Market | 20,000 | $210K | 8/1/2025 |
| Greg Keenan | ▼ Sell | Open Market | 8,305 | $68K | 3/7/2025 |
| Joseph M. Miller | ▼ Sell | Open Market | 56,154 | $445K | 3/4/2025 |
| Stephen P. Robertson | ▼ Sell | Open Market | 57,607 | $456K | 3/4/2025 |
| Matthew Maxwell Donley | ▼ Sell | Open Market | 58,991 | $467K | 3/4/2025 |
| Kevin Tang | ▲ Buy | Open Market | 148,038 | $1.2M | 3/4/2025 |
| Kevin Tang | ▲ Buy | Open Market | 500,000 | $4.0M | 3/4/2025 |
| Kevin Tang | ▲ Buy | Open Market | 100,000 | $809K | 3/4/2025 |
| Peter Greenleaf | ▼ Sell | Open Market | 164,947 | $1.3M | 3/4/2025 |
| Peter Greenleaf | ▲ Buy | Grant | 333,705 | $0 | 3/3/2025 |
| Peter Greenleaf | ▼ Sell | Open Market | 195,593 | $1.6M | 3/3/2025 |
| Greg Keenan | ▼ Sell | Open Market | 12,239 | $98K | 3/3/2025 |
| Joseph M. Miller | ▲ Buy | Grant | 114,711 | $0 | 3/3/2025 |
| Joseph M. Miller | ▼ Sell | Open Market | 61,859 | $495K | 3/3/2025 |
| Stephen P. Robertson | ▲ Buy | Grant | 102,406 | $0 | 3/3/2025 |
| Stephen P. Robertson | ▼ Sell | Open Market | 64,872 | $519K | 3/3/2025 |
| Matthew Maxwell Donley | ▲ Buy | Grant | 135,567 | $0 | 3/3/2025 |
| Matthew Maxwell Donley | ▼ Sell | Open Market | 65,902 | $527K | 3/3/2025 |
| Kevin Tang | ▲ Buy | Open Market | 100,720 | $803K | 3/3/2025 |
| Kevin Tang | ▲ Buy | Open Market | 351,962 | $2.8M | 3/3/2025 |
| Peter Greenleaf | ▲ Buy | Grant | 290,728 | $0 | 2/28/2025 |
| Greg Keenan | ▲ Buy | Grant | 62,583 | $0 | 2/28/2025 |
| Joseph M. Miller | ▲ Buy | Grant | 81,457 | $0 | 2/28/2025 |
| Stephen P. Robertson | ▲ Buy | Grant | 84,106 | $0 | 2/28/2025 |
| Matthew Maxwell Donley | ▲ Buy | Grant | 82,781 | $0 | 2/28/2025 |
| Kevin Tang | ▲ Buy | Open Market | 399,280 | $3.1M | 2/28/2025 |
| Kevin Tang | ▲ Buy | Open Market | 500,000 | $4.5M | 12/9/2024 |
| Kevin Tang | ▲ Buy | Open Market | 400,000 | $3.6M | 12/6/2024 |
| Kevin Tang | ▲ Buy | Open Market | 300,000 | $2.7M | 12/5/2024 |
| Smith Karen L. | ▲ Buy | Grant | 12,135 | $0 | 11/21/2024 |
| Leversage Jill | ▲ Buy | Grant | 12,135 | $0 | 11/21/2024 |
| Craig A. Johnson | ▲ Buy | Grant | 20,631 | $0 | 11/21/2024 |
| Jeffrey Allen Bailey | ▲ Buy | Grant | 12,135 | $0 | 11/21/2024 |
| Jayne David R.W. | ▲ Buy | Grant | 12,135 | $0 | 11/21/2024 |
| Jeffrey Allen Bailey | ▼ Sell | Open Market | 4,557 | $38K | 11/11/2024 |
| Smith Karen L. | ▼ Sell | Open Market | 5,241 | $44K | 11/11/2024 |
| Jeffrey Allen Bailey | ▲ Buy | Option Exercise | 17,913 | — | 11/8/2024 |
| Smith Karen L. | ▲ Buy | Option Exercise | 17,913 | — | 11/8/2024 |
| Habig Scott Michael | ▼ Sell | Open Market | 18,249 | $97K | 8/6/2024 |
| Balakrishnan Brinda | ▼ Sell | Open Market | 520 | $3K | 5/21/2024 |
| Billen Daniel | ▼ Sell | Open Market | 5,252 | $30K | 5/21/2024 |
| Jayne David R.W. | ▼ Sell | Open Market | 4,946 | $28K | 5/21/2024 |
| Leversage Jill | ▼ Sell | Open Market | 5,610 | $32K | 5/21/2024 |
| MacKay-Dunn R. Hector | ▼ Sell | Open Market | 5,630 | $32K | 5/21/2024 |
| Peter Greenleaf | ▼ Sell | Open Market | 126,981 | $711K | 3/6/2024 |
| Joseph M. Miller | ▼ Sell | Open Market | 34,811 | $195K | 3/6/2024 |
| Matthew Maxwell Donley | ▼ Sell | Open Market | 40,665 | $224K | 3/6/2024 |
| Habig Scott Michael | ▼ Sell | Open Market | 17,777 | $100K | 3/6/2024 |
| Stephen P. Robertson | ▼ Sell | Open Market | 57,745 | $323K | 3/6/2024 |
| Knappertz Volker | ▼ Sell | Open Market | 4,930 | $30K | 2/27/2024 |
| Knappertz Volker | ▼ Sell | Open Market | 25,146 | $138K | 2/20/2024 |
| Habig Scott Michael | ▲ Buy | Grant | 195,512 | $0 | 2/20/2024 |
| Habig Scott Michael | ▼ Sell | Open Market | 15,867 | $87K | 2/20/2024 |
| Matthew Maxwell Donley | ▲ Buy | Grant | 216,666 | $0 | 2/20/2024 |
| Stephen P. Robertson | ▲ Buy | Grant | 194,230 | $0 | 2/20/2024 |
| Joseph M. Miller | ▲ Buy | Grant | 196,153 | $0 | 2/20/2024 |
| Peter Greenleaf | ▲ Buy | Grant | 661,538 | $0 | 2/20/2024 |
| Leversage Jill | ▼ Sell | Open Market | 4,815 | $54K | 5/23/2023 |
| MacKay-Dunn R. Hector | ▼ Sell | Open Market | 4,818 | $54K | 5/23/2023 |
| Jayne David R.W. | ▼ Sell | Open Market | 8,733 | $98K | 5/23/2023 |
| Billen Daniel | ▼ Sell | Open Market | 4,650 | $52K | 5/23/2023 |
| MacKay-Dunn R. Hector | ▲ Buy | Grant | 9,310 | $0 | 5/19/2023 |
| Leversage Jill | ▲ Buy | Grant | 9,310 | $0 | 5/19/2023 |
| Balakrishnan Brinda | ▲ Buy | Grant | 9,310 | $0 | 5/19/2023 |
| Jayne David R.W. | ▲ Buy | Grant | 9,310 | $0 | 5/19/2023 |
| Hagan Joseph P | ▼ Sell | Open Market | 272 | $3K | 5/19/2023 |
| Billen Daniel | ▲ Buy | Grant | 9,310 | $0 | 5/19/2023 |
| MILNE GEORGE M JR | ▲ Buy | Option Exercise | 8,733 | — | 5/18/2023 |
| MacKay-Dunn R. Hector | ▲ Buy | Option Exercise | 8,733 | — | 5/18/2023 |
| Leversage Jill | ▲ Buy | Option Exercise | 8,733 | — | 5/18/2023 |
| Balakrishnan Brinda | ▲ Buy | Option Exercise | 8,733 | — | 5/18/2023 |
| Jayne David R.W. | ▲ Buy | Option Exercise | 8,733 | — | 5/18/2023 |
| Hagan Joseph P | ▲ Buy | Option Exercise | 8,733 | — | 5/18/2023 |
| Billen Daniel | ▲ Buy | Option Exercise | 8,733 | — | 5/18/2023 |
| Stephen P. Robertson | ▼ Sell | Open Market | 19,402 | $173K | 3/2/2023 |
| Habig Scott Michael | ▲ Buy | Grant | 170,188 | — | 3/2/2023 |
| Knappertz Volker | ▲ Buy | Grant | 191,462 | $0 | 3/2/2023 |
| Joseph M. Miller | ▲ Buy | Grant | 229,421 | — | 3/2/2023 |
| Joseph M. Miller | ▼ Sell | Open Market | 11,296 | $101K | 3/2/2023 |
| Stephen P. Robertson | ▲ Buy | Grant | 204,810 | — | 3/2/2023 |
| MILNE GEORGE M JR | ▲ Buy | Open Market | 20,000 | $178K | 3/2/2023 |
| Peter Greenleaf | ▲ Buy | Grant | 667,407 | — | 3/2/2023 |
| Peter Greenleaf | ▼ Sell | Open Market | 32,750 | $293K | 3/2/2023 |
| Martin Michael Robert | ▲ Buy | Grant | 107,202 | — | 3/2/2023 |
| Matthew Maxwell Donley | ▲ Buy | Grant | 271,134 | — | 3/2/2023 |
| Matthew Maxwell Donley | ▲ Buy | Open Market | 10,000 | $47K | 11/21/2022 |
| Habig Scott Michael | ▲ Buy | Open Market | 5,000 | $25K | 11/9/2022 |
| Martin Michael Robert | ▲ Buy | Open Market | 30,000 | $155K | 11/7/2022 |
| MacKay-Dunn R. Hector | ▲ Buy | Open Market | 5,000 | $55K | 3/9/2022 |
| MILNE GEORGE M JR | ▲ Buy | Open Market | 5,000 | $54K | 3/4/2022 |
| Matthew Maxwell Donley | ▲ Buy | Grant | 8,500 | $0 | 3/2/2022 |
| Colao Massimilano | ▲ Buy | Grant | 8,500 | $0 | 3/2/2022 |
| Matthew Maxwell Donley | ▼ Sell | Open Market | 3,052 | $37K | 3/2/2022 |
| Joseph M. Miller | ▲ Buy | Grant | 8,500 | $0 | 3/2/2022 |
| Joseph M. Miller | ▼ Sell | Open Market | 3,060 | $37K | 3/2/2022 |
| Colao Massimilano | ▼ Sell | Open Market | 3,205 | $38K | 3/2/2022 |
| Stephen P. Robertson | ▲ Buy | Grant | 8,500 | $0 | 3/2/2022 |
| Solomons Neil | ▲ Buy | Grant | 8,500 | $0 | 3/2/2022 |
| Solomons Neil | ▼ Sell | Open Market | 4,846 | $58K | 3/2/2022 |
| Huizinga Robert Bindert | ▲ Buy | Grant | 8,500 | $0 | 3/2/2022 |
| Huizinga Robert Bindert | ▼ Sell | Open Market | 4,849 | $58K | 3/2/2022 |
| Martin Michael Robert | ▲ Buy | Grant | 8,500 | $0 | 3/2/2022 |
| Peter Greenleaf | ▲ Buy | Grant | 28,300 | $0 | 3/2/2022 |
| Peter Greenleaf | ▼ Sell | Open Market | 9,068 | $109K | 3/2/2022 |
| Martin Michael Robert | ▼ Sell | Open Market | 4,849 | $58K | 3/2/2022 |
| Hagan Joseph P | ▲ Buy | Option Exercise | 40,000 | $203K | 1/3/2022 |
| Hagan Joseph P | ▼ Sell | Open Market | 634 | $15K | 1/3/2022 |
| Hagan Joseph P | ▼ Sell | Open Market | 39,366 | $889K | 1/3/2022 |
| Leversage Jill | ▲ Buy | Open Market | 1,600 | $32K | 12/13/2021 |
| Solomons Neil | ▲ Buy | Option Exercise | 100,000 | $530K | 11/11/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 29,000 | $533K | 11/11/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 29,000 | $836K | 11/11/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 11,000 | $325K | 11/11/2021 |
| Solomons Neil | ▼ Sell | Open Market | 100,000 | $2.9M | 11/11/2021 |
| Solomons Neil | ▲ Buy | Option Exercise | 70,000 | $424K | 11/10/2021 |
| Solomons Neil | ▲ Buy | Option Exercise | 30,000 | $159K | 11/10/2021 |
| Solomons Neil | ▼ Sell | Open Market | 90,000 | $2.8M | 11/10/2021 |
| Solomons Neil | ▼ Sell | Open Market | 10,000 | $306K | 11/10/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 50,000 | $1.6M | 11/10/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 10,000 | $306K | 11/10/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 50,000 | $1.5M | 11/9/2021 |
| Solomons Neil | ▼ Sell | Open Market | 50,000 | $1.5M | 11/9/2021 |
| Solomons Neil | ▲ Buy | Option Exercise | 45,000 | $239K | 11/1/2021 |
| Solomons Neil | ▼ Sell | Open Market | 45,000 | $1.4M | 11/1/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 45,000 | $144K | 11/1/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 45,000 | $1.4M | 11/1/2021 |
| Huizinga Robert Bindert | ▲ Buy | Option Exercise | 95,000 | $304K | 10/25/2021 |
| Huizinga Robert Bindert | ▼ Sell | Open Market | 130,000 | $3.9M | 10/25/2021 |
| Huizinga Robert Bindert | ▲ Buy | Option Exercise | 16,000 | $42K | 9/21/2021 |
| Huizinga Robert Bindert | ▲ Buy | Option Exercise | 11,136 | $36K | 9/21/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 7,500 | $40K | 9/21/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 10,000 | $184K | 9/21/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 87,500 | $2.1M | 9/21/2021 |
| Huizinga Robert Bindert | ▼ Sell | Open Market | 27,136 | $653K | 9/21/2021 |
| Huizinga Robert Bindert | ▼ Sell | Open Market | 5,364 | $127K | 9/21/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 70,000 | $424K | 9/21/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 28,500 | $151K | 9/20/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 12,500 | $271K | 9/20/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 16,000 | $346K | 9/20/2021 |
| Huizinga Robert Bindert | ▼ Sell | Open Market | 22,500 | $489K | 9/14/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 44,000 | $233K | 9/14/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 30,000 | $654K | 9/14/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 14,000 | $304K | 9/14/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 45,000 | $239K | 9/14/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 45,000 | $144K | 9/14/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 90,000 | $1.9M | 9/14/2021 |
| Solomons Neil | ▲ Buy | Option Exercise | 150,000 | $480K | 9/13/2021 |
| Martin Michael Robert | ▲ Buy | Option Exercise | 25,000 | $133K | 9/13/2021 |
| Huizinga Robert Bindert | ▼ Sell | Open Market | 5,000 | $99K | 9/10/2021 |
| Solomons Neil | ▼ Sell | Open Market | 150,000 | $3.0M | 9/10/2021 |
| Huizinga Robert Bindert | ▼ Sell | Open Market | 5,000 | $99K | 9/10/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 25,000 | $495K | 9/10/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 7,500 | $136K | 9/7/2021 |
| Huizinga Robert Bindert | ▼ Sell | Open Market | 5,000 | $92K | 9/7/2021 |
| Martin Michael Robert | ▼ Sell | Open Market | 22,500 | $401K | 8/26/2021 |
| Solomons Neil | ▼ Sell | Open Market | 5,000 | $79K | 8/25/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
AUPH Appears in Report on Activist Investor Activity
Aurinia Pharmaceuticals was mentioned among stocks drawing attention from activist investors, according to recent financial news coverage. No specific activist involvement details or corporate action plans were detailed in the report. The stock is currently trading between its 52-week range extremes, with analysts maintaining price targets notably above current levels.
AUPH Appears in Report on Activist Investor Activity. Aurinia Pharmaceuticals was mentioned among stocks drawing attention from activist investors, according to recent financial news coverage. No specific activist involvement details or corporate action plans were detailed in the report. The stock is currently trading between its 52-week range extremes, with analysts maintaining price targets notably above current levels.